Key result
Prophylactic use of inotropic agents to prevent low cardiac output states in adults undergoing cardiac surgery is the focus of this Cochrane Review protocol, which reports no clinical results.
Why the study?
To assess the efficacy and safety of the prophylactic use of any inotropic drug for the prevention of low cardiac output states and associated morbidity and mortality in adults undergoing cardiac surgery.
Does the prophylactic use of any inotropic drug prevent low cardiac output states and associated morbidity and mortality in adults undergoing cardiac surgery?
Does the prophylactic use of any inotropic drug prevent low cardiac output states and associated morbidity and mortality in adults undergoing cardiac surgery?
This protocol outlines a planned Cochrane Review to evaluate whether prophylactic inotropic agents prevent low cardiac output syndrome and mortality in adults undergoing cardiac surgery.
Answers are grounded in this paper and cite their sources.
No results yet on prophylactic inotropes post-cardiac surgery; protocol leaves open their efficacy for systematic review.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the efficacy and safety of the prophylactic use of any inotropic drug for the prevention of low cardiac output states and associated morbidity and mortality, in adults undergoing cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Gayatri et al. (2020) studied this question. Prophylactic use of inotropic agents to prevent low cardiac output states in adults undergoing cardiac surgery is the focus of this Cochrane Review protocol, which reports no clinical results.
Synapse has enriched 10 related papers. Consider them for comparative context: